The Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease
The Effects of a High Intensity Exercise Training Program on Sleep and Vigilance in Patients With Parkinson's Disease (The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD Patients)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: PD participants
- Subjects with a clinical diagnosis of idiopathic Parkinson's disease based on the presence of bradykinesia and one or both of the following: rest tremor and/or rigidity
- Hoehn and Yahr stage 2 or 3
- Stable dopaminergic medication regimen for at least 4 weeks prior to study entry without anticipation of medication change for the duration of the study.
- Stable doses of medications known to affect sleep and medications for Parkinson's disease for at least 4 weeks prior to study entry without anticipation of medication change for the duration of the study.
- Age 45 or greater at time of study entry
- Asymmetric onset of PD
- Progressive motor symptoms of PD
- Poor sleep quality (Pittsburgh Sleep Quality Index score >5)
- MoCA score 18-26
- Ability to travel to UAB 3x/week for the 16 weeks duration of the study for exercise training sessions as well as for other study visits
- Subjects must pass a physical examination and PAR-Q to assess exercise readiness
Inclusion Criteria: Healthy Controls
- Age 45 or greater at time of study entry
- Poor sleep quality (Pittsburgh Sleep Quality Index score >5)
- Normal cognition
Exclusion Criteria: PD Participants
- Atypical features indicative of a Parkinson's Plus disorder (Progressive Supranuclear Palsy, Multiple Systems Atrophy, Corticobasal Degeneration) including cerebellar signs, supranuclear gaze palsy, apraxia, prominent autonomic failure, or other cortical signs.
- Neuroleptic treatment at time of onset of Parkinsonism
- Active treatment with a neuroleptic at time of study entry
- History of multiple strokes with stepwise progression of Parkinsonism
- History of multiple head injuries
- Inability to walk without assistance, including a cane, wheelchair, or walker
- Regular participation in an exercise program within the past 6 months
- Deep Brain Stimulation
- Untreated sleep apnea
- Known narcolepsy
- Participation in drug studies or the use of investigational drugs within 30 days prior to screening
- Acute illness or active, confounding medical, neurological, or musculoskeletal conditions that, at the discretion of the PI, would prevent the subject's ability to participate in the study
- Known contraindication to testing
- Active alcoholism or other drug addiction
- Pregnancy
Exclusion criteria for PD subjects undergoing imaging studies:
- Pacemaker or other metallic object that would make MR imaging unsafe
- Claustrophobia that prevents participation in imaging portion
- Any motor, cognitive, or health disorder that in the opinion of the PI would prevent the subject from participating in the imaging portion
Exclusion criteria for healthy controls:
- Pacemaker or other metallic object that would make MR imaging unsafe
- Claustrophobia that prevents participation in imaging portion
- Any motor, cognitive, or health disorder that in the opinion of the PI would prevent the subject from participating in the imaging portion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: PD exercise group
Supervised exercise training, 3x per week for 16 weeks
|
Supervised high intensity exercise 3x/week for 16 weeks
|
|
Active Comparator: PD sleep hygeine group
Tips for improved sleep hygiene, reading materials
|
Sleep medicine physician will provide discuss sleep habits with participants, provide tips for improving sleep hygiene, and provide reading materials.
|
|
No Intervention: Healthy control
MRI sub-study only
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sleep efficiency measured by polysomnography
Time Frame: baseline, week 18, and week 34
|
polysomnography
|
baseline, week 18, and week 34
|
|
Vigilance outcome measured by psychomotor vigilance task (PVT)
Time Frame: baseline, week 18, and week 34
|
psychomotor vigilance task (PVT)
|
baseline, week 18, and week 34
|
|
Motor outcome measured by Timed up and go test (TUG)
Time Frame: baseline, week 18, and week 34
|
Timed up and go test (TUG)
|
baseline, week 18, and week 34
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Home sleep environment
Time Frame: baseline, week 18 and week 34
|
comparison of sleep diaries and actigraph related to home sleep environment
|
baseline, week 18 and week 34
|
|
MRI Sub-study
Time Frame: baseline (both PD and control), week 18 (PD only)
|
comparison of PD and control imaging scans
|
baseline (both PD and control), week 18 (PD only)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Amy Amara, MD, PhD, University of Alabama at Birmingham
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- F150612003
- 5K23NS080912 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.